Janssen Search
Search results
Discovery, Product Development & Supply
Discovery, Product Development & Supply (DPDS) is the molecular invention, development, and delivery engine within Janssen. Our team targets the hardest-to-treat diseases, combining the expertise of our multi-disciplinary scientists with external ...
Sexual and Gender Minority Health Equity in Prostate Cancer Care
Sexual and Gender Minority Health Equity in Prostate Cancer Care For decades, researchers, healthcare professionals, patients and their loved ones have come together to advance treatment and care for people diagnosed with prostate cancer. Clinical ...
ASCO GU 2021
Thank you for visiting the Janssen Oncology newsroom to learn more about our research that will be presented at the American Society of Clinical Oncology 2021 Genitourinary Cancers Symposium (ASCO GU). Janssen Oncology has 12 company-sponsored ...
Immunology
Immunology Immunology Air-liquid interface culture of colonic epithelial cells; Clara Moon, Janssen R&D Skin cells at 20x magnification About Our Immunology Innovations Discoveries in Immunology Disease Treatment Development Capabilities ...
Johnson & Johnson Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Pediatric Indication for HIV-1 Therapy PREZCOBIX®
Jun 04, 2024 If approved, PREZCOBIX® would offer a new HIV-1 treatment option for pediatric patients aged 6 and older weighing at least 25 kg Titusville, N.J. (June 4, 2024) – Johnson & Johnson today announced the submission of a supplemental New Drug ...
Building Equitable Access For Patients With Lung Cancer
Building Equitable Access to Next-Generation Sequencing and Targeted Therapies for All Patients With Lung Cancer The cancer research landscape looked vastly different when I began my career almost 15 years ago. As just one example, when I graduated from ...
Hematologic Malignancies (Blood Cancers)
Hematologic Malignancies (Blood Cancers) There has been significant progress in the treatment of people diagnosed with blood cancers over the past 50 years. Our leadership has advanced transformative therapies for hematologic malignancies, and we are ...
Neuroscience
"With neuroscience as part of Janssen's origin story, we are focused on brain health, actively searching for solutions for all the people living with disorders of the nervous system." Bill Martin, Ph.D. GLOBAL THERAPEUTIC AREA HEAD The ...
Thinking Differently about Health Care: A Finnish Formula for Collaboration
Thinking Differently about Health Care: A Finnish Formula for Collaboration In our ever-evolving health care landscape, where patients’ desire for improved health and researchers’ ability to innovate grow in tandem, the medical industry is becoming more ...
Kevin Wildenhaus, Ph.D.
KEVIN WILDENHAUS, PH.D. BEHAVIORAL SCIENCE LEAD WORLD WITHOUT DISEASE ACCELERATOR As Behavioral Science Lead for the World Without Disease Accelerator (WWDA), Kevin leads behavioral science efforts across the WWDA portfolio. His responsibility within the ...